McRae Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinder Morgan
KMI
|
+$905K |
| 2 |
Labcorp
LH
|
+$558K |
| 3 |
CVS Health
CVS
|
+$222K |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$209K |
| 5 |
Middlesex Water
MSEX
|
+$201K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TUP
Tupperware Brands Corporation
TUP
|
+$4.58M |
| 2 |
Procter & Gamble
PG
|
+$3.36M |
| 3 |
Pfizer
PFE
|
+$2.55M |
| 4 |
US Bancorp
USB
|
+$2.14M |
| 5 |
SPDR Gold Trust
GLD
|
+$977K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.72% |
| 2 | Healthcare | 18.25% |
| 3 | Consumer Discretionary | 17.7% |
| 4 | Financials | 16.71% |
| 5 | Communication Services | 6.78% |
Similar funds
McRae Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, McRae Capital Management held 101 positions worth $236M, down 1.3% from $239M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
McRae Capital Management withdrew a net $19.1M in Q3 2018, closing 5 positions and reducing 53 holdings. Its most notable exit was Tupperware Brands Corporation, an estimated $4.58M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, McRae Capital Management opened a new position in CVS Health worth $244K.
- McRae Capital Management's largest Q3 2018 buy was CVS Health: 3,100 shares worth $244K.
- McRae Capital Management added most to Kinder Morgan in Q3 2018, an estimated $905K increase.
- McRae Capital Management's biggest Q3 2018 reduction was Procter & Gamble, cutting an estimated $3.36M.
- McRae Capital Management fully exited Tupperware Brands Corporation in Q3 2018, selling an estimated $4.58M.
- McRae Capital Management's ten largest holdings make up 47% of its $236M portfolio in Q3 2018.
- McRae Capital Management opened 4 new positions and closed 5 in Q3 2018.
- McRae Capital Management's portfolio value fell 1.3% quarter-over-quarter to $236M.
Based on McRae Capital Management's 13F filing for Q3 2018, filed 15 Oct 2018.